Australia markets closed

Bioasis Technologies Inc. (BTI.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.00500.0000 (0.00%)
As of 03:52PM EDT. Market open.
Full screen
Previous close0.0050
Open0.0050
Bid0.0050 x 0
Ask0.0050 x 0
Day's range0.0050 - 0.0050
52-week range0.0050 - 0.0200
Volume814
Avg. volume34,256
Market cap397,070
Beta (5Y monthly)0.42
PE ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings date19 Jan 2024 - 22 Jan 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Bioasis Provides Corporate Update and Announces Suspension of Operations

    NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor and a differentiated, proprietary xB3 ™ platform for delivering therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, today provided an up